SIPA1 knocked down in breast cancer cells significantly reduced FAK and Akt phosphorylation and inhibited MMP9 extracellular secretion through the integrin-mediated FAK/AKT-MMP9 signaling pathway. Here, AKT1 is linked to breast carcinoma.